Breaking News, Promotions & Moves

Trinity Life Sciences Names Leslie Orne CEO

Orne has over 20 years of leadership experience consulting in the life sciences industry.

Trinity Lifesciences, a company involved in global life sciences commercialization solutions, appointed Leslie Orne as Chief Executive Officer, effective July 1.

Orne, currently the president and chief commercial officer at Trinity, succeeds David Fitzhenry, who has held various leadership roles at Trinity for 26 years. Fitzhenry will remain active with the company as a strategic advisor and member of the board of directors.

Orne, who is also a member of Trinity’s board of directors, has over 20 years of leadership experience consulting in the life sciences industry. She has overseen the delivery of integrated consulting, insights, and analytics services to Trinity’s 300-plus clients since 2001.

According to the company, her support for billions of dollars in strategic transactions and the launches of dozens of products gives Leslie a unique vantage point on the industry.

Orne has played an integral role in Trinity’s acquisitions over the last few years, shepherding the integration of BluePrint Research Group, CBPartners and D Cube Analytics into the Trinity fold. Ms. Orne has also spearheaded Trinity’s strategic partnerships with Bain & Company and Havas Health & You.  

“Trinity’s vision, mission and values are extremely important to me, and none of that will change,” said Orne. “Someday we or someone we love will be patients. I’m committed to the urgent pursuit of progress so that we can help our clients bring life-changing treatments to patients faster and more efficiently. Our industry is fast-paced, and Trinity has the passion and resources to drive new commercialization innovations that advance the entire healthcare ecosystem.”

“Trinity has consistently outpaced the market in terms of growth, and we have never been better positioned than we are today to have a real influence on getting the right products to the right patients at the right time,” said David Fitzhenry, current CEO of Trinity Life Sciences. “Leslie’s laser-focused growth mindset will be essential during the next chapter of Trinity’s expansion.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters